These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33269892)

  • 1. Case Series: Novel Utilization of Rho-Kinase Inhibitor for the Treatment of Corneal Edema.
    Davies E
    Cornea; 2021 Jan; 40(1):116-120. PubMed ID: 33269892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.
    Davies E; Jurkunas U; Pineda R
    Cornea; 2021 Jul; 40(7):899-902. PubMed ID: 33758139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy.
    Price MO; Price FW
    Am J Ophthalmol; 2021 Jul; 227():100-105. PubMed ID: 33737034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series.
    Wisely CE; Liu KC; Gupta D; Carlson AN; Asrani SG; Kim T
    Am J Ophthalmol; 2020 Sep; 217():20-26. PubMed ID: 32289295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil: A Case Series and Review.
    LoBue SA; Moustafa GA; Vu A; Amin M; Nguyen T; Goyal H
    Cornea; 2021 Aug; 40(8):1048-1054. PubMed ID: 33369939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ROCK inhibitor netarsudil in the treatment of corneal endothelial decompensation caused by corneal endotheliitis: A case report and literature review.
    Li S; Liu Z; Deng S; Zhang Y; Jie Y
    Int Immunopharmacol; 2024 Jul; 136():112195. PubMed ID: 38820965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil.
    Chen H; McMillin JC; Frankfort BJ; Al-Mohtaseb Z
    J Glaucoma; 2020 Nov; 29(11):e124-e126. PubMed ID: 32826765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticular Epithelial Edema in Edematous Corneas Treated with Netarsudil.
    Fernandez MM
    Ophthalmology; 2018 Nov; 125(11):1709. PubMed ID: 30318038
    [No Abstract]   [Full Text] [Related]  

  • 9. Honeycomb Epithelial Edema Associated With Rho Kinase Inhibition: A Case Series and Review of the Literature.
    Lyons LJ; Wu KY; Baratz KH; Sit AJ
    Cornea; 2022 Feb; 41(2):243-248. PubMed ID: 35037906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs.
    Casanova MI; Park S; Mayes MA; Roszak K; Ferneding M; Echeverria N; Bowman MAW; Michalak SR; Ardon M; Wong S; Le SM; Daley N; Leonard BC; Good KL; Li JY; Thomasy SM
    Sci Rep; 2024 Mar; 14(1):6238. PubMed ID: 38485975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Rho Kinase Inhibitors in Corneal Diseases.
    Futterknecht S; Chatzimichail E; Gugleta K; Panos GD; Gatzioufas Z
    Drug Des Devel Ther; 2024; 18():97-108. PubMed ID: 38264539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.
    Syed ZA; Rapuano CJ
    Curr Opin Ophthalmol; 2021 May; 32(3):268-274. PubMed ID: 33606407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible Corneal Endothelial Abnormalities With Netarsudil.
    Tanna AP; Esfandiari H; Teramoto K
    J Glaucoma; 2020 Jun; 29(6):e41-e43. PubMed ID: 32224803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netarsudil-associated reticular corneal epithelial edema.
    Tran JA; Jurkunas UV; Yin J; Davies EC; Sola-Del Valle DA; Chen TC; Lin MM
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101287. PubMed ID: 35146185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing.
    Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2).
    Kahook MY; Serle JB; Mah FS; Kim T; Raizman MB; Heah T; Ramirez-Davis N; Kopczynski CC; Usner DW; Novack GD;
    Am J Ophthalmol; 2019 Apr; 200():130-137. PubMed ID: 30653957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Topical Netarsudil in the Treatment of a Neurotrophic Corneal Ulcer.
    Bronner AW
    Optom Vis Sci; 2022 Jul; 99(7):589-592. PubMed ID: 35413038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhopressa-induced corneal edema: a case report.
    Chu MJ; Song M; Palmares T; Song A; Song J
    J Med Case Rep; 2021 Apr; 15(1):182. PubMed ID: 33810801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series.
    Moumneh K; Sheybani A; Fellman RL; Godfrey DG; Grover DS
    J Glaucoma; 2020 Jul; 29(7):607-610. PubMed ID: 32398584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty.
    Chen SL; LoBue SA; Goyal H
    Am J Ophthalmol Case Rep; 2021 Jun; 22():101087. PubMed ID: 33997467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.